Veristat Formalizes its Strategic Decision Consulting Services
SOUTHBOROUGH, MA – November 01, 2016 – Veristat, a full-service consultative Clinical Research Organization (CRO), announced today the formal...
Veristat Strengthens Its Long-Standing Relationship with Aegerion Pharmaceuticals
Veristat, a full service Clinical Research Organization (CRO), announced today the signing of a Preferred Provider Agreement (PPA) with ...
Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s...
Veristat Continues To Be Recognized for Its Positive Impact & Company Growth
SOUTHBOROUGH, MA – August 17, 2016 – Veristat announced today...
Veristat Article “Adaptive Designs- Recent Advancement in Clinical Trials” Published in...
Two of Veristat’s statistical and adaptive design experts submitted a research paper which was published in the June 2016 issue of the ...
Fueled by Growth, Veristat Continues Geographic Expansion in North Carolina
Accelerates Hiring & Plans to Open Office in Raleigh-Durham, North Carolina
Veristat Strengthens Statistical Consulting and Adaptive Design Trial Expertise With...
Appoints Mark Chang as Senior Vice President of Strategic Statistical Consulting
SOUTHBOROUGH, MA – June 15, 2016 – Veristat, a full...
Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology
SOUTHBOROUGH, MA – May 2, 2016 – Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its...
Veristat Ranked #35 on Boston Business Journal’s “Fast 50” List, the Top 50 Fastest Growing...
Veristat Recognized as One of the Top 50 Fastest-Growing Private Companies in Massachusetts
Veristat, a full service Clinical Research...